257 related articles for article (PubMed ID: 17083476)
21. Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.
Yamaguchi F; Morrison RS; Gonatas NK; Takahashi H; Sugisaki Y; Teramoto A
Int J Oncol; 2003 May; 22(5):1045-9. PubMed ID: 12684670
[TBL] [Abstract][Full Text] [Related]
22. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
[TBL] [Abstract][Full Text] [Related]
23. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.
Mishima K; Kato Y; Kaneko MK; Nishikawa R; Hirose T; Matsutani M
Acta Neuropathol; 2006 May; 111(5):483-8. PubMed ID: 16596424
[TBL] [Abstract][Full Text] [Related]
24. Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody.
Battula VL; Treml S; Abele H; Bühring HJ
Differentiation; 2008 Apr; 76(4):326-36. PubMed ID: 17924962
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Numb expression in astrocytomas.
Yan B; Omar FM; Das K; Ng WH; Lim C; Shiuan K; Yap CT; Salto-Tellez M
Neuropathology; 2008 Oct; 28(5):479-84. PubMed ID: 18384513
[TBL] [Abstract][Full Text] [Related]
26. Identification of 14-3-3 protein isoforms in human astrocytoma by immunohistochemistry.
Cao L; Cao W; Zhang W; Lin H; Yang X; Zhen H; Cheng J; Dong W; Huo J; Zhang X
Neurosci Lett; 2008 Feb; 432(2):94-9. PubMed ID: 18242847
[TBL] [Abstract][Full Text] [Related]
27. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
[TBL] [Abstract][Full Text] [Related]
29. Cathepsin D is a potential serum marker for poor prognosis in glioma patients.
Fukuda ME; Iwadate Y; Machida T; Hiwasa T; Nimura Y; Nagai Y; Takiguchi M; Tanzawa H; Yamaura A; Seki N
Cancer Res; 2005 Jun; 65(12):5190-4. PubMed ID: 15958563
[TBL] [Abstract][Full Text] [Related]
30. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
[TBL] [Abstract][Full Text] [Related]
31. The glucose transporter and blood-brain barrier of human brain tumors.
Guerin C; Laterra J; Hruban RH; Brem H; Drewes LR; Goldstein GW
Ann Neurol; 1990 Dec; 28(6):758-65. PubMed ID: 2178329
[TBL] [Abstract][Full Text] [Related]
32. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
[TBL] [Abstract][Full Text] [Related]
33. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
[TBL] [Abstract][Full Text] [Related]
34. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
Wang DL; Wang YF; Shi GS; Huang H
Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
[TBL] [Abstract][Full Text] [Related]
35. Diversity of glial cell components in pilocytic astrocytoma.
Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
[TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic value of NDRG2 in human astrocytomas.
Li L; Wang J; Shen X; Wang L; Li X; Liu Y; Shi M; Zhao G; Deng Y
J Neurol Sci; 2011 Sep; 308(1-2):77-82. PubMed ID: 21705028
[TBL] [Abstract][Full Text] [Related]
37. Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas.
Gutenberg A; Brück W; Buchfelder M; Ludwig HC
Acta Neuropathol; 2004 Sep; 108(3):224-30. PubMed ID: 15221336
[TBL] [Abstract][Full Text] [Related]
38. Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature.
Tchoghandjian A; Fernandez C; Colin C; El Ayachi I; Voutsinos-Porche B; Fina F; Scavarda D; Piercecchi-Marti MD; Intagliata D; Ouafik L; Fraslon-Vanhulle C; Figarella-Branger D
Brain; 2009 Jun; 132(Pt 6):1523-35. PubMed ID: 19336457
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies.
Torp SH
Clin Neuropathol; 2002; 21(6):252-7. PubMed ID: 12489673
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical estimation of cell cycle entry and phase distribution in astrocytomas: applications in diagnostic neuropathology.
Scott IS; Morris LS; Rushbrook SM; Bird K; Vowler SL; Burnet NG; Coleman N
Neuropathol Appl Neurobiol; 2005 Oct; 31(5):455-66. PubMed ID: 16150117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
